Olympic Cards

< -5%

Inland Printers

Infomedia Press

Veritaas Advert

HT Media

-5% to -3%

S Chand and Co

Sandesh

DB Corp

Next Mediaworks

Hindustan Media

Cyber Media

JagranPrakashan

Sambhaav Media

-3% to 0%

Navneet

Repro India

0% to 3%

Shakti Press

Diligent Media 

3% to 5%

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and listings, here’s a quick look at which stocks will be in focus in today's trade:

<a href="https://www.moneycontrol.com/markets/earnings/" target="_blank">Results Today</a>

Tata Motors Passenger Vehicles, Siemens, Oil India, Glenmark Pharmaceuticals, Brainbees Solutions Firstcry, Marico, Natco Pharma, Allcargo Logistics, Ashoka Buildcon, Carraro India, Engineers India, Exide Industries, Gujarat Mineral Development Corporation, Godawari Power and Ispat, Inox Wind, Max Healthcare Institute, Narayana Hrudayalaya, Pace Digitek, Rashtriya Chemicals and Fertilizers, Sun TV Network, and Utkarsh Small Finance Bank will release their quarterly earnings today.

<a href="https://www.moneycontrol.com/markets/earnings/" target="_blank">Quarterly Earnings</a>

<a href="https://www.moneycontrol.com/india/stockpricequote/automobile-truckslcvs/tatamotors/TML02" target="_blank">Tata Motors Commercial Vehicles</a> Q2 (Consolidated YoY)

Loss stands at Rs 867 crore Vs profit of Rs 498 crore

Revenue rises 6% to Rs 18,585 crore Vs Rs 17,535 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-23-wheelers/heromotocorp/HHM" target="_blank">Hero MotoCorp</a> Q2 (Standalone)

Profit grows 15.7% to Rs 1,392.8 crore Vs Rs 1,203.5 crore

Revenue increases 15.9% to Rs 12,126.4 crore Vs Rs 10,463.2 crore

Board approves additional investment of Rs 170 crore for setting up of Global Part Center (GPC ) 2.0 at Tirupati, Andhra Pradesh

LG Electronics India Q2 (YoY)

Profit falls 27.3% to Rs 389.4 crore Vs Rs 535.7 crore

Revenue grows 1% to Rs 6,174 crore Vs Rs 6,113.9 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/tyres/apollotyres/AT14" target="_blank">Apollo Tyres</a> Q2 (Consolidated YoY)

Profit declines 13.2% to Rs 258 crore Vs Rs 297.5 crore

Revenue rises 6.1% to Rs 6,831.1 crore Vs Rs 6,437 crore

Exceptional loss at Rs 180 crore Vs Rs 5.2 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/computers-software-mediumsmall/sonatasoftware/SS42" target="_blank">Sonata Software</a> Q2 (Consolidated YoY)

Profit increases 12.9% to Rs 120.2 crore Vs Rs 106.5 crore

Revenue falls 2.3% to Rs 2,119.3 crore Vs Rs 2,169.8 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/finance-investment/nationalsecuritiesdepository/NSD01" target="_blank">National Securities Depository</a> (NSDL) Q2 (Consolidated YoY)

Profit grows 14.8% to Rs 110.4 crore Vs Rs 96.2 crore

Revenue soars 12.2% to Rs 400 crore Vs Rs 356.7 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/consumer-goods-electronic/pgelectroplast/PE06" target="_blank">PG Electroplast</a> Q2 (Consolidated YoY)

Profit sinks 85.7% to Rs 2.8 crore Vs Rs 19.3 crore

Revenue declines 2.4% to Rs 655.4 crore Vs Rs 671.3 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticalsdrugs/akumsdrugspharmaceuticals/ADP03" target="_blank">Akums Drugs and Pharmaceuticals</a> Q2 (Consolidated YoY)

Profit slips 37.5% to Rs 40.8 crore Vs Rs 65.2 crore

Revenue drops 1.5% to Rs 1,017.5 crore Vs Rs 1,033 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/aerospacedefence/bharatdynamics/BDL01" target="_blank">Bharat Dynamics</a> Q2 (Standalone YoY)

Profit zooms 76.2% to Rs 215.9 crore Vs Rs 122.5 crore

Revenue grows 110.6% to Rs 1,147 crore Vs Rs 544.8 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/consumer-food/orklaindia/OIL02" target="_blank">Orkla India</a> Q2 (Consolidated YoY)

Profit falls 7.3% to Rs 76.7 crore Vs Rs 82.7 crore

Revenue rises 4.9% to Rs 650.3 crore Vs Rs 619.8 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/miscellaneous/jubilantfoodworks/JF04" target="_blank">Jubilant Foodworks</a> Q2 (Consolidated YoY)

Profit spikes 190.5% to Rs 186 crore Vs Rs 64 crore

Revenue grows 19.7% to Rs 2,340.2 crore Vs Rs 1,954.7 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/householdpersonal-products/vishalmegamart/VMML" target="_blank">Vishal Mega Mart</a> Q2 (Consolidated YoY)

Profit zooms 46.5% to Rs 152.3 crore Vs Rs 104 crore

Revenue soars 22.4% to Rs 2,981.5 crore Vs Rs 2,436.2 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/finance-investments/muthootfinance/MF10" target="_blank">Muthoot Finance</a> Q2 (Standalone YoY)

Profit spikes 87.4% to Rs 2,345.2 crore Vs Rs 1,251.1 crore

Revenue zooms 58.5% to Rs 3,991.7 crore Vs Rs 2,518 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/textiles-readymade-apparels/dollarindustries/DI29" target="_blank">Dollar Industries</a> Q2 (Consolidated YoY)

Profit grows 32.7% to Rs 35.2 crore Vs Rs 26.5 crore

Revenue increases 5.6% to Rs 471.9 crore Vs Rs 446.9 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/constructioncontracting-civil/dilipbuildcon/DB04" target="_blank">Dilip Buildcon</a> Q2 (Consolidated YoY)

Profit falls 22.8% to Rs 181.5 crore Vs Rs 235.2 crore

Revenue declines 21.8% to Rs 1,925.9 crore Vs Rs 2,461.3 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/engineering-industrial-equipments/tegaindustries/TI26" target="_blank">Tega Industries</a> Q2 (Consolidated YoY)

Profit zooms 522.5% to Rs 44.9 crore Vs Rs 7.2 crore

Revenue increases 14.7% to Rs 405.4 crore Vs Rs 353.3 crore

<a href="https://www.moneycontrol.com/india/stockpricequote/food-processing/krbl/KRB01" target="_blank">KRBL</a> Q2 (Consolidated YoY)

Profit surges 67.6% to Rs 172.1 crore Vs Rs 102.7 crore

Revenue jumps 18.9% to Rs 1,511.1 crore Vs Rs 1,270.5 crore

Stocks to Watch

<a href="https://www.moneycontrol.com/india/stockpricequote/miscellaneous/sagility/SIL27" target="_blank">Sagility</a>

A promoter entity is likely to sell up to a 16.4% stake in Sagility via block deals, with a floor price of Rs 46.4 per share, reports CNBC-TV18, citing sources.

<a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticalsdrugs/zyduslifesciences/CHC" target="_blank">Zydus Lifesciences</a>

The United States Food and Drug Administration (USFDA) conducted a Pre-Approval Inspection at the SEZ Oncology Injectable manufacturing site in SEZ-1, Ahmedabad, related to the new isolator injectable line, during November 4–13. The inspection concluded with two observations, with no data-integrity–related issues.

Additionally, Zydus has received final approval from the USFDA for Diroximel Fumarate delayed-release capsules, 231 mg. These capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults.

<a href="https://www.moneycontrol.com/india/stockpricequote/infrastructure-general/nbccindia/NBC01" target="_blank">NBCC (India)</a>

The company has received an order worth Rs 340 crore for the construction of the Central University of Kashmir (Phase-I works) at Tulmulla, Ganderbal, Kashmir.

<a href="https://www.moneycontrol.com/india/stockpricequote/miscellaneous/nipponlifeindiaassetmanagement/RNL" target="_blank">Nippon Life India Asset Management</a>

The Board has authorised Nippon Life to enter into a strategic collaboration with DWS Group GmbH &amp; Co. KGaA, the European asset manager. Both parties intend to jointly develop and build a leading AIF franchise in India, wherein DWS plans to acquire a minority stake of up to 40% in Nippon Life India AIF Management (NAIF), a wholly owned subsidiary of the company.

<a href="https://www.moneycontrol.com/india/stockpricequote/power-generationdistribution/cesc/CES" target="_blank">CESC</a>

The company’s subsidiary, CESC Green Power, has received in-principle approval from the Government of Odisha to set up a manufacturing facility comprising 3 GW solar cell capacity, 3 GW solar module capacity, a 5 GWh advanced chemistry battery cell pack unit, and advanced solar components, along with a 60 MW AC captive power plant in the Dhenkanal district. The investment is estimated at around Rs 4,500 crore in three phases.

<a href="https://www.moneycontrol.com/india/stockpricequote/construction-real-estate/surajestatedevelopers/SED01" target="_blank">Suraj Estate Developers</a>

The real estate developer announced the launch of its commercial project, One Business Bay, having a carpet area of 2.09 lakh sq ft, with an estimated Gross Development Value (GDV) of Rs 1,200 crore.

<a href="https://www.moneycontrol.com/india/stockpricequote/aerospacedefence/bharatdynamics/BDL01" target="_blank">Bharat Dynamics</a>

BDL has signed a contract worth Rs 2,095.70 crore with the Ministry of Defence for the supply of Invar anti-tank missiles to the Indian Army.

<a href="https://www.moneycontrol.com/india/stockpricequote/pesticidesagro-chemicals/rallisindia/RI03" target="_blank">Rallis India</a>

The company announced its partnership with Paryan Alliance as the licensed technology partner for FullPage Herbicide Tolerance Rice Technology in India.

Block Deals

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-ancillaries-brakes/atherenergy/AEL09" target="_blank">Ather Energy</a>

National Investment and Infrastructure Fund II (NIIF), owned by the Government and a group of institutional investors, sold 87.02 lakh equity shares (equivalent to 2.28% of the paid-up equity) in Ather Energy, the Bengaluru-based electric two-wheeler maker, at Rs 622.35 per share, amounting to Rs 541.57 crore.

As of September 2025, NIIF held 1.77 crore equity shares, or a 4.67 percent stake, in Ather Energy.

The 2.28 percent stake was acquired by several domestic and global institutional investors, including Ghisallo Master Fund, Invesco Mutual Fund, Motilal Oswal Mutual Fund, Param Capital, Societe Generale, and Ashoka Whiteoak ICAV.

<a href="https://www.moneycontrol.com/india/stockpricequote/banks-private-sector/axisbank/AB16" target="_blank">Axis Bank</a>

Societe Generale picked up 91,177 equity shares in Axis Bank at Rs 1,221.6 per share for Rs 11.1 crore from BofA Securities Europe SA.

<a href="https://www.moneycontrol.com/india/stockpricequote/finance-nbfc/tatacapital/TCL06" target="_blank">Tata Capital</a>

Societe Generale bought 11.53 lakh shares in Tata Capital at Rs 325.2 per share for Rs 37.5 crore from Marshall Wace Investment Strategies – Eureka Fund.

<a href="https://www.moneycontrol.com/india/stockpricequote/finance-housing/sammaancapital/IHF01" target="_blank">Sammaan Capital</a>

Societe Generale acquired 88.24 lakh shares in Sammaan Capital at Rs 176.97 per share for Rs 156.16 crore from Citigroup Global Markets Mauritius and Morgan Stanley Asia Singapore.

Bulk Deals

<a href="https://www.moneycontrol.com/india/stockpricequote/electronics-components/supremepowerequipment/SPEL" target="_blank">Supreme Power Equipment</a>, <a href="https://www.moneycontrol.com/india/stockpricequote/electric-equipment/salzerelectronics/SE01" target="_blank">Salzer Electronics</a>

Varanium Capital Advisors, the asset management firm, bought 2.4 lakh shares in Supreme Power Equipment at Rs 227.42 per share for Rs 5.45 crore, and 1.6 lakh shares in Salzer Electronics at Rs 772.62 per share, valued at Rs 12.36 crore.

Mainboard Listing

Pine Labs

SME Listing

Curis Lifesciences
Shining Tools

Stocks Trade Ex-Date for Buyback

Infosys
GHCL

Stocks Trade Ex-Dividend

Oil and Natural Gas Corporation
Petronet LNG
National Aluminium Company
ASM Technologies
Bayer CropScience
Birlasoft
D-Link (India)
Emami
Esab India
Ganesh Consumer Products
Garware Technical Fibres
GPT Healthcare
HCP Plastene Bulkpack
Indag Rubber
Indian Toners &amp; Developers
JM Financial
KDDL
KP Energy
KP Green Engineering
KPI Green Energy
Mafatlal Industries
MOIL
Nava
Premco Global
Pricol
RITES
Safari Industries India
Saksoft
Veedol Corporation
Vidhi Specialty Food Ingredients

Stock Trades Ex-Date for Split &amp; Bonus

Sampre Nutritions
Sampre Nutritions

Stock Trades Ex-Date for Bonus

SMC Global Securities

Stock Trades Ex-Date for Split

Websol Energy System

Stock Trades Ex-Date for Income Distribution (InvIT)

Anzen India Energy Yield Plus Trust
IndiGrid Infrastructure Trust
Interise Trust
Maple Infrastructure Trust

Stocks Trade Ex-Date for Rights

Allcargo Terminals
Tuni Textile Mills

Stock in F&amp;O ban

SAIL

Ownership, Material Conflicts of Interest and Disciplinary History

MCD is a wholly owned subsidiary of Network 18 Media & Investments Ltd ("Network18"), in which Independent Media Trust (IMT) holds 56.89% stake. Reliance Industries Limited ("RIL") is the sole beneficiary of IMT. Network18 and RIL and their subsidiaries, joint ventures and associates can be considered as associates of MCD.

Details of Associate

Receipt of Compensation

Third-Party Compensation

Employment History

Market-Making Activities

Use of Artificial Intelligence

Stocks to Watch Today: Hero Moto, Tata Motors, Pine Labs, Sagility, Zydus Life, LG Electronics, NBCC, Nippon Life, BDL, Muthoot Finance, Vishal Mega Mart in focus on 14 November

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and listings, here’s a quick look at which stocks will be in focus in today's trade:

Results Today

Tata Motors Passenger Vehicles, Siemens, Oil India, Glenmark Pharmaceuticals, Brainbees Solutions Firstcry, Marico, Natco Pharma, Allcargo Logistics, Ashoka Buildcon, Carraro India, Engineers India, Exide Industries, Gujarat Mineral Development Corporation, Godawari Power and Ispat, Inox Wind, Max Healthcare Institute, Narayana Hrudayalaya, Pace Digitek, Rashtriya Chemicals and Fertilizers, Sun TV Network, and Utkarsh Small Finance Bank will release their quarterly earnings today.

Quarterly Earnings

Tata Motors Commercial Vehicles Q2 (Consolidated YoY)

Loss stands at Rs 867 crore Vs profit of Rs 498 crore

Revenue rises 6% to Rs 18,585 crore Vs Rs 17,535 crore

Hero MotoCorp Q2 (Standalone)

Profit grows 15.7% to Rs 1,392.8 crore Vs Rs 1,203.5 crore

Revenue increases 15.9% to Rs 12,126.4 crore Vs Rs 10,463.2 crore

Board approves additional investment of Rs 170 crore for setting up of Global Part Center (GPC ) 2.0 at Tirupati, Andhra Pradesh

LG Electronics India Q2 (YoY)

Profit falls 27.3% to Rs 389.4 crore Vs Rs 535.7 crore

Revenue grows 1% to Rs 6,174 crore Vs Rs 6,113.9 crore

Apollo Tyres Q2 (Consolidated YoY)

Profit declines 13.2% to Rs 258 crore Vs Rs 297.5 crore

Revenue rises 6.1% to Rs 6,831.1 crore Vs Rs 6,437 crore

Exceptional loss at Rs 180 crore Vs Rs 5.2 crore

Sonata Software Q2 (Consolidated YoY)

Profit increases 12.9% to Rs 120.2 crore Vs Rs 106.5 crore

Revenue falls 2.3% to Rs 2,119.3 crore Vs Rs 2,169.8 crore

National Securities Depository (NSDL) Q2 (Consolidated YoY)

Profit grows 14.8% to Rs 110.4 crore Vs Rs 96.2 crore

Revenue soars 12.2% to Rs 400 crore Vs Rs 356.7 crore

PG Electroplast Q2 (Consolidated YoY)

Profit sinks 85.7% to Rs 2.8 crore Vs Rs 19.3 crore

Revenue declines 2.4% to Rs 655.4 crore Vs Rs 671.3 crore

Akums Drugs and Pharmaceuticals Q2 (Consolidated YoY)

Profit slips 37.5% to Rs 40.8 crore Vs Rs 65.2 crore

Revenue drops 1.5% to Rs 1,017.5 crore Vs Rs 1,033 crore

Bharat Dynamics Q2 (Standalone YoY)

Profit zooms 76.2% to Rs 215.9 crore Vs Rs 122.5 crore

Revenue grows 110.6% to Rs 1,147 crore Vs Rs 544.8 crore

Orkla India Q2 (Consolidated YoY)

Profit falls 7.3% to Rs 76.7 crore Vs Rs 82.7 crore

Revenue rises 4.9% to Rs 650.3 crore Vs Rs 619.8 crore

Jubilant Foodworks Q2 (Consolidated YoY)

Profit spikes 190.5% to Rs 186 crore Vs Rs 64 crore

Revenue grows 19.7% to Rs 2,340.2 crore Vs Rs 1,954.7 crore

Vishal Mega Mart Q2 (Consolidated YoY)

Profit zooms 46.5% to Rs 152.3 crore Vs Rs 104 crore

Revenue soars 22.4% to Rs 2,981.5 crore Vs Rs 2,436.2 crore

Muthoot Finance Q2 (Standalone YoY)

Profit spikes 87.4% to Rs 2,345.2 crore Vs Rs 1,251.1 crore

Revenue zooms 58.5% to Rs 3,991.7 crore Vs Rs 2,518 crore

Dollar Industries Q2 (Consolidated YoY)

Profit grows 32.7% to Rs 35.2 crore Vs Rs 26.5 crore

Revenue increases 5.6% to Rs 471.9 crore Vs Rs 446.9 crore

Dilip Buildcon Q2 (Consolidated YoY)

Profit falls 22.8% to Rs 181.5 crore Vs Rs 235.2 crore

Revenue declines 21.8% to Rs 1,925.9 crore Vs Rs 2,461.3 crore

Tega Industries Q2 (Consolidated YoY)

Profit zooms 522.5% to Rs 44.9 crore Vs Rs 7.2 crore

Revenue increases 14.7% to Rs 405.4 crore Vs Rs 353.3 crore

KRBL Q2 (Consolidated YoY)

Profit surges 67.6% to Rs 172.1 crore Vs Rs 102.7 crore

Revenue jumps 18.9% to Rs 1,511.1 crore Vs Rs 1,270.5 crore

Stocks to Watch

Sagility

A promoter entity is likely to sell up to a 16.4% stake in Sagility via block deals, with a floor price of Rs 46.4 per share, reports CNBC-TV18, citing sources.

Zydus Lifesciences

The United States Food and Drug Administration (USFDA) conducted a Pre-Approval Inspection at the SEZ Oncology Injectable manufacturing site in SEZ-1, Ahmedabad, related to the new isolator injectable line, during November 4–13. The inspection concluded with two observations, with no data-integrity–related issues.

Additionally, Zydus has received final approval from the USFDA for Diroximel Fumarate delayed-release capsules, 231 mg. These capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults.

NBCC (India)

The company has received an order worth Rs 340 crore for the construction of the Central University of Kashmir (Phase-I works) at Tulmulla, Ganderbal, Kashmir.

Nippon Life India Asset Management

The Board has authorised Nippon Life to enter into a strategic collaboration with DWS Group GmbH &amp;amp; Co. KGaA, the European asset manager. Both parties intend to jointly develop and build a leading AIF franchise in India, wherein DWS plans to acquire a minority stake of up to 40% in Nippon Life India AIF Management (NAIF), a wholly owned subsidiary of the company.

CESC

The company’s subsidiary, CESC Green Power, has received in-principle approval from the Government of Odisha to set up a manufacturing facility comprising 3 GW solar cell capacity, 3 GW solar module capacity, a 5 GWh advanced chemistry battery cell pack unit, and advanced solar components, along with a 60 MW AC captive power plant in the Dhenkanal district. The investment is estimated at around Rs 4,500 crore in three phases.

Suraj Estate Developers

The real estate developer announced the launch of its commercial project, One Business Bay, having a carpet area of 2.09 lakh sq ft, with an estimated Gross Development Value (GDV) of Rs 1,200 crore.

Bharat Dynamics

BDL has signed a contract worth Rs 2,095.70 crore with the Ministry of Defence for the supply of Invar anti-tank missiles to the Indian Army.

Rallis India

The company announced its partnership with Paryan Alliance as the licensed technology partner for FullPage Herbicide Tolerance Rice Technology in India.

Block Deals

Ather Energy

National Investment and Infrastructure Fund II (NIIF), owned by the Government and a group of institutional investors, sold 87.02 lakh equity shares (equivalent to 2.28% of the paid-up equity) in Ather Energy, the Bengaluru-based electric two-wheeler maker, at Rs 622.35 per share, amounting to Rs 541.57 crore.

As of September 2025, NIIF held 1.77 crore equity shares, or a 4.67 percent stake, in Ather Energy.

The 2.28 percent stake was acquired by several domestic and global institutional investors, including Ghisallo Master Fund, Invesco Mutual Fund, Motilal Oswal Mutual Fund, Param Capital, Societe Generale, and Ashoka Whiteoak ICAV.

Axis Bank

Societe Generale picked up 91,177 equity shares in Axis Bank at Rs 1,221.6 per share for Rs 11.1 crore from BofA Securities Europe SA.

Tata Capital

Societe Generale bought 11.53 lakh shares in Tata Capital at Rs 325.2 per share for Rs 37.5 crore from Marshall Wace Investment Strategies – Eureka Fund.

Sammaan Capital

Societe Generale acquired 88.24 lakh shares in Sammaan Capital at Rs 176.97 per share for Rs 156.16 crore from Citigroup Global Markets Mauritius and Morgan Stanley Asia Singapore.

Bulk Deals

Supreme Power Equipment, Salzer Electronics

Varanium Capital Advisors, the asset management firm, bought 2.4 lakh shares in Supreme Power Equipment at Rs 227.42 per share for Rs 5.45 crore, and 1.6 lakh shares in Salzer Electronics at Rs 772.62 per share, valued at Rs 12.36 crore.

Mainboard Listing

Pine Labs

SME Listing

Curis Lifesciences
Shining Tools

Stocks Trade Ex-Date for Buyback

Infosys
GHCL

Stocks Trade Ex-Dividend

Oil and Natural Gas Corporation
Petronet LNG
National Aluminium Company
ASM Technologies
Bayer CropScience
Birlasoft
D-Link (India)
Emami
Esab India
Ganesh Consumer Products
Garware Technical Fibres
GPT Healthcare
HCP Plastene Bulkpack
Indag Rubber
Indian Toners &amp;amp; Developers
JM Financial
KDDL
KP Energy
KP Green Engineering
KPI Green Energy
Mafatlal Industries
MOIL
Nava
Premco Global
Pricol
RITES
Safari Industries India
Saksoft
Veedol Corporation
Vidhi Specialty Food Ingredients

Stock Trades Ex-Date for Split &amp;amp; Bonus

Sampre Nutritions
Sampre Nutritions

Stock Trades Ex-Date for Bonus

SMC Global Securities

Stock Trades Ex-Date for Split

Websol Energy System

Stock Trades Ex-Date for Income Distribution (InvIT)

Anzen India Energy Yield Plus Trust
IndiGrid Infrastructure Trust
Interise Trust
Maple Infrastructure Trust

Stocks Trade Ex-Date for Rights

Allcargo Terminals
Tuni Textile Mills

Stock in F&amp;amp;O ban

SAIL

National Investment and Infrastructure Fund II (NIIF), owned by the Government and a group of institutional investors, offloaded a 2.28 percent equity stake in Ather Energy, the Bengaluru-based electric two-wheeler maker, through open market transactions on November 13.

<a href="https://www.moneycontrol.com/india/stockpricequote/auto-ancillaries-brakes/atherenergy/AEL09">Ather Energy</a> shares rose 1.7 percent to Rs 639.15 and have remained range-bound for over a week.

NIIF sold 87.02 lakh equity shares (equivalent to 2.28 percent of the paid-up equity) in the company at Rs 622.35 per share, amounting to Rs 541.57 crore.

As of September 2025, NIIF held 1.77 crore equity shares, or a 4.67 percent stake, in Ather Energy.

The 2.28 percent stake was acquired by several domestic and global institutional investors, including Ghisallo Master Fund, Invesco Mutual Fund, Motilal Oswal Mutual Fund, Param Capital, Societe Generale, and Ashoka Whiteoak ICAV.

Among other block deals, Societe Generale picked up 91,177 equity shares in <a href="https://www.moneycontrol.com/india/stockpricequote/banks-private-sector/axisbank/AB16">Axis Bank</a> at Rs 1,221.6 per share for Rs 11.1 crore from BofA Securities Europe SA, and 11.53 lakh shares in <a href="https://www.moneycontrol.com/india/stockpricequote/finance-nbfc/tatacapital/TCL06">Tata Capital</a> at Rs 325.2 per share for Rs 37.5 crore from Marshall Wace Investment Strategies – Eureka Fund.

Further, Societe Generale acquired 88.24 lakh shares in <a href="https://www.moneycontrol.com/india/stockpricequote/finance-housing/sammaancapital/IHF01">Sammaan Capital</a> at Rs 176.97 per share for Rs 156.16 crore from Citigroup Global Markets Mauritius and Morgan Stanley Asia Singapore.

Meanwhile, <a href="https://www.moneycontrol.com/india/stockpricequote/electronics-components/supremepowerequipment/SPEL">Supreme Power Equipment</a> and <a href="https://www.moneycontrol.com/india/stockpricequote/electric-equipment/salzerelectronics/SE01">Salzer Electronics</a> were also in focus on Thursday. The former’s shares rallied more than 6 percent to close at Rs 207.65, while the latter’s shares surged 13.6 percent to Rs 782.55 on the NSE.

Varanium Capital Advisors, the asset management firm, bought 2.4 lakh shares in Supreme Power Equipment at Rs 227.42 per share for Rs 5.45 crore, and 1.6 lakh shares in Salzer Electronics at Rs 772.62 per share, valued at Rs 12.36 crore.

National Investment and Infrastructure Fund sells 2.28% stake in Ather Energy to 8 investors

National Investment and Infrastructure Fund II (NIIF), owned by the Government and a group of institutional investors, offloaded a 2.28 percent equity stake in Ather Energy, the Bengaluru-based electric two-wheeler maker, through open market transactions on November 13.

Ather Energy shares rose 1.7 percent to Rs 639.15 and have remained range-bound for over a week.

NIIF sold 87.02 lakh equity shares (equivalent to 2.28 percent of the paid-up equity) in the company at Rs 622.35 per share, amounting to Rs 541.57 crore.

As of September 2025, NIIF held 1.77 crore equity shares, or a 4.67 percent stake, in Ather Energy.

The 2.28 percent stake was acquired by several domestic and global institutional investors, including Ghisallo Master Fund, Invesco Mutual Fund, Motilal Oswal Mutual Fund, Param Capital, Societe Generale, and Ashoka Whiteoak ICAV.

Among other block deals, Societe Generale picked up 91,177 equity shares in Axis Bank at Rs 1,221.6 per share for Rs 11.1 crore from BofA Securities Europe SA, and 11.53 lakh shares in Tata Capital at Rs 325.2 per share for Rs 37.5 crore from Marshall Wace Investment Strategies – Eureka Fund.

Further, Societe Generale acquired 88.24 lakh shares in Sammaan Capital at Rs 176.97 per share for Rs 156.16 crore from Citigroup Global Markets Mauritius and Morgan Stanley Asia Singapore.

Meanwhile, Supreme Power Equipment and Salzer Electronics were also in focus on Thursday. The former’s shares rallied more than 6 percent to close at Rs 207.65, while the latter’s shares surged 13.6 percent to Rs 782.55 on the NSE.

Varanium Capital Advisors, the asset management firm, bought 2.4 lakh shares in Supreme Power Equipment at Rs 227.42 per share for Rs 5.45 crore, and 1.6 lakh shares in Salzer Electronics at Rs 772.62 per share, valued at Rs 12.36 crore.

The shares of <a href="https://www.moneycontrol.com/india/stockpricequote/travel-services/yatraonline/YO">Yatra Online</a> jumped up to 6 percent on November 13, extending sharp gains for the third consecutive session after the firm released strong results for the second quarter of the ongoing financial year 2026. The stock has now gained more than 35 percent in just three sessions.

The company had released its results on November 11. The shares hit a 52-week high of Rs 196.30 apiece earlier yesterday.

Yatra Online Q2 Results:

Yatra Online reported a consolidated net profit of Rs 14.28 crore for the July-September quarter of FY26. This is nearly double that of the Rs 7.3 crore net profit reported in the corresponding quarter of the previous financial year.

The firm's revenue from operations meanwhile jumped over 48 percent year-on-year (YoY) to Rs 350.87 crore in Q2 FY26, from Rs 236.40 crore in Q2 FY25. EBITDA surged 125 percent YoY to Rs 24.8 crore during the quarter under review, with EBITDA margin at 20 percent.

Yatra Online announced that its gross debt reduced from Rs 54.6 crore in March to Rs 21.1 crore in September, reflecting its strong liquidity position.

“Looking ahead, we remain focused on scaling high-margin segments, deepening technology capabilities, and driving sustainable long-term value for stakeholders. On the back of the strong momentum we are also raising our Adjusted EBITDA guidance for the full year from the current growth guidance of 30% to a revised growth guidance of 35% - 40%,” said Yatra Online Whole Time Director cum CEO Dhruv Shringi.

Brokerages on Yatra Online:

JM Financial increased the target price for the stock to Rs 215 apiece from Rs 190 apiece, while maintaining its ‘Buy’ call. The latest target price implies an upside potential of more than 16 percent from the stock’s previous closing price.

The domestic brokerage said that the company delivered a healthy performance in Q2 led by strong momentum in its Hotels &amp; Packages (H&amp;P) segment.

“The management raised its FY26 guidance for revenue less service costs to 22–23% (from 20% earlier) and Adj. EBITDA growth to 35–40% (from 30%+) underpinned by robust corporate traction and improving operating leverage. We, however, continue to build above guidance estimates due to strong corporate client additions and margin normalisation expected in 2H,” JM Financial said.

Antique Stock Broking has a ‘Buy’ call on the stock, while raising the target price to Rs 230 per share. This implies an upside potential of more than 24 percent from the stock’s previous closing price.

The brokerage anticipates continued strong performance and expects the company’s FY26 PAT to rise to Rs 60 crore.

Also read:<a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-sensex-nifty-50-share-price-gift-nifty-latest-updates-13-11-2025-liveblog-13672643.html"> Our LIVE blog on stock market updates</a>

(With inputs from Reuters)

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Yatra Online shares jump 35% in three days as brokerages raise target prices after strong Q2 results

The shares of Yatra Online jumped up to 6 percent on November 13, extending sharp gains for the third consecutive session after the firm released strong results for the second quarter of the ongoing financial year 2026. The stock has now gained more than 35 percent in just three sessions.

The company had released its results on November 11. The shares hit a 52-week high of Rs 196.30 apiece earlier yesterday.

Yatra Online Q2 Results:

Yatra Online reported a consolidated net profit of Rs 14.28 crore for the July-September quarter of FY26. This is nearly double that of the Rs 7.3 crore net profit reported in the corresponding quarter of the previous financial year.

The firm's revenue from operations meanwhile jumped over 48 percent year-on-year (YoY) to Rs 350.87 crore in Q2 FY26, from Rs 236.40 crore in Q2 FY25. EBITDA surged 125 percent YoY to Rs 24.8 crore during the quarter under review, with EBITDA margin at 20 percent.

Yatra Online announced that its gross debt reduced from Rs 54.6 crore in March to Rs 21.1 crore in September, reflecting its strong liquidity position.

“Looking ahead, we remain focused on scaling high-margin segments, deepening technology capabilities, and driving sustainable long-term value for stakeholders. On the back of the strong momentum we are also raising our Adjusted EBITDA guidance for the full year from the current growth guidance of 30% to a revised growth guidance of 35% - 40%,” said Yatra Online Whole Time Director cum CEO Dhruv Shringi.

Brokerages on Yatra Online:

JM Financial increased the target price for the stock to Rs 215 apiece from Rs 190 apiece, while maintaining its ‘Buy’ call. The latest target price implies an upside potential of more than 16 percent from the stock’s previous closing price.

The domestic brokerage said that the company delivered a healthy performance in Q2 led by strong momentum in its Hotels &amp;amp; Packages (H&amp;amp;P) segment.

“The management raised its FY26 guidance for revenue less service costs to 22–23% (from 20% earlier) and Adj. EBITDA growth to 35–40% (from 30%+) underpinned by robust corporate traction and improving operating leverage. We, however, continue to build above guidance estimates due to strong corporate client additions and margin normalisation expected in 2H,” JM Financial said.

Antique Stock Broking has a ‘Buy’ call on the stock, while raising the target price to Rs 230 per share. This implies an upside potential of more than 24 percent from the stock’s previous closing price.

The brokerage anticipates continued strong performance and expects the company’s FY26 PAT to rise to Rs 60 crore.

Also read: Our LIVE blog on stock market updates

(With inputs from Reuters)

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

The shares of <a href="https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/biocon/BL03">Biocon</a> extended sharp gains for the second consecutive session on November 13 after the pharma company’s strong Q2 results boosted investor sentiment. Brokerages remain positive for the stock, raising target prices after the earnings announcement.

Biocon shares rose more than 4 percent to trade at Rs 423.10 apiece on Thursday. The stock has now gained nearly 10 percent in these two sessions since the company’s earnings announcement in the post market hours of November 11 (Tuesday).

Biocon Q2 Results:

Biocon reported a <a href="https://www.moneycontrol.com/news/results/biocon-reports-rs-85-crore-net-profit-in-q2fy26-13669963.html">consolidated net profit</a> of Rs 84.5 crore for the July-September quarter of the ongoing financial year 2026. This comes against a net loss of Rs 16 crore reported during the corresponding quarter of the previous financial year.

The firm’s revenue from operations meanwhile rose nearly 20 percent year-on-year (YoY) to Rs 4,295.5 crore in Q2 FY26, from Rs 3,590.4 crore reported in Q2 FY25. Its expenses grew over 18 percent YoY to Rs 4,205.3 crore during the quarter under review.

JM Financial on Biocon:

JM Financial kept a ‘Buy’ call on Biocon shares, while raising their target price to Rs 476 apiece. This implies an upside potential of more than 17 percent from the stock’s previous closing price. The domestic brokerage noted that the firm’s biosimilars grew at a “stellar” rate of 25 percent YoY, driven by market share gains and successful launches including bUstekinumab, bAspart, bBevacizumab and bAflibercept.

“We have revised our FY26/27/28 estimates on account of biosimilar ramp-up, the muted EBITDA trajectory and higher than anticipated minority payments. We remain confident on the company’s future prospects owing to the biosimilar scale-up, new launches, improving leverage and balance sheet strengthening,” it added.

Axis Securities on Biocon:

Axis Securities had a ‘Buy’ call on the stock, while raising its target price to Rs 450 per share. This implies an upside potential of around 10 percent from the stock’s previous closing price. The domestic brokerage said that the firm’s revenue, EBITDA margins and PAT were in-line with its estimates.

“Management expects strong double-digit revenue growth in FY26, driven by sustained momentum in Biosimilars, margin recovery in Generics from H2, and steady growth in the CRDMO segment. Recent launches, including Yesintek, Yesafili, Bevacizumab, Insulin Aspart, and Denosumab, are expected to accelerate growth in the Biosimilars business. Profitability is likely to improve through new generic launches such as Liraglutide, Sacubitril/Valsartan, and Everolimus, coupled with operating leverage benefits. Following the Rs 4,500 Cr QIP, debt reduction, and a strengthened balance sheet provide further flexibility to pursue future growth opportunities. Management remains confident of sustaining revenue momentum and delivering margin expansion in FY26 and beyond,” Axis said.

Follow all Q2 updates LIVE <a href="https://www.moneycontrol.com/news/business/earnings/q2-results-2025-live-updates-paras-defence-nbcc-ndsl-tata-steel-hal-muthoot-finance-lg-india-hero-motocorp-voltas-jubilant-foodworks-quarterly-earnings-13-november-2025-liveblog-13673702.html">here</a>.

Motilal Oswal on Biocon:

Motilal Oswal has a ‘Buy’ call on the stock, with a target price of Rs 480 per share. This implies an upside potential of more than 18 percent from the stock’s previous closing price. The domestic brokerage said that the firm’s revenue and EBITDA were in-line with its estimates, while PAT was better than expected due to lower minority interest for the quarter.

It has however trimmed its earnings estimate for the stock to factor in procedural time required to add Insulin Aspart biosimilar in the formulary list, gradual reduction in interest costs, and R&amp;D spending to boost product pipeline across the biosimilar/generics segments.

“Following an earnings revival in FY25, BIOS is entering a scale-up phase, poised for strong earnings growth driven by robust traction across segments and improved profitability. Ongoing financial deleverage is expected to further enhance earnings prospects,” it added.

Goldman Sachs on Biocon:

Goldman Sachs remained ‘Neutral’ on the stock, but raised its target price to Rs 375 per share. This implies a downside potential of nearly 8 percent from the stock’s previous closing price.

The international brokerage said that the results beat estimates driven largely by beats from the generics and biologics segments

HBSC Research on Biocon:

HBSC Research held a ‘Buy’ call on the stock, and raised its target price to Rs 455 per share. This implies an upside potential of more than 12 percent from the stock’s previous closing price.

The international brokerage said that it remains positive on imminent turnaround of company's biosimilars segment.

Also read: <a href="https://www.moneycontrol.com/news/business/markets/stock-market-live-sensex-nifty-50-share-price-gift-nifty-latest-updates-13-11-2025-liveblog-13672643.html">Our LIVE blog on stock market updates</a>

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Biocon shares surge 10% in two days as brokerages cheer firm’s strong Q2 results: Check latest target prices

The shares of Biocon extended sharp gains for the second consecutive session on November 13 after the pharma company’s strong Q2 results boosted investor sentiment. Brokerages remain positive for the stock, raising target prices after the earnings announcement.

Biocon shares rose more than 4 percent to trade at Rs 423.10 apiece on Thursday. The stock has now gained nearly 10 percent in these two sessions since the company’s earnings announcement in the post market hours of November 11 (Tuesday).

Biocon Q2 Results:

Biocon reported a consolidated net profit of Rs 84.5 crore for the July-September quarter of the ongoing financial year 2026. This comes against a net loss of Rs 16 crore reported during the corresponding quarter of the previous financial year.

The firm’s revenue from operations meanwhile rose nearly 20 percent year-on-year (YoY) to Rs 4,295.5 crore in Q2 FY26, from Rs 3,590.4 crore reported in Q2 FY25. Its expenses grew over 18 percent YoY to Rs 4,205.3 crore during the quarter under review.

JM Financial on Biocon:

JM Financial kept a ‘Buy’ call on Biocon shares, while raising their target price to Rs 476 apiece. This implies an upside potential of more than 17 percent from the stock’s previous closing price. The domestic brokerage noted that the firm’s biosimilars grew at a “stellar” rate of 25 percent YoY, driven by market share gains and successful launches including bUstekinumab, bAspart, bBevacizumab and bAflibercept.

“We have revised our FY26/27/28 estimates on account of biosimilar ramp-up, the muted EBITDA trajectory and higher than anticipated minority payments. We remain confident on the company’s future prospects owing to the biosimilar scale-up, new launches, improving leverage and balance sheet strengthening,” it added.

Axis Securities on Biocon:

Axis Securities had a ‘Buy’ call on the stock, while raising its target price to Rs 450 per share. This implies an upside potential of around 10 percent from the stock’s previous closing price. The domestic brokerage said that the firm’s revenue, EBITDA margins and PAT were in-line with its estimates.

“Management expects strong double-digit revenue growth in FY26, driven by sustained momentum in Biosimilars, margin recovery in Generics from H2, and steady growth in the CRDMO segment. Recent launches, including Yesintek, Yesafili, Bevacizumab, Insulin Aspart, and Denosumab, are expected to accelerate growth in the Biosimilars business. Profitability is likely to improve through new generic launches such as Liraglutide, Sacubitril/Valsartan, and Everolimus, coupled with operating leverage benefits. Following the Rs 4,500 Cr QIP, debt reduction, and a strengthened balance sheet provide further flexibility to pursue future growth opportunities. Management remains confident of sustaining revenue momentum and delivering margin expansion in FY26 and beyond,” Axis said.

Follow all Q2 updates LIVE here.

Motilal Oswal on Biocon:

Motilal Oswal has a ‘Buy’ call on the stock, with a target price of Rs 480 per share. This implies an upside potential of more than 18 percent from the stock’s previous closing price. The domestic brokerage said that the firm’s revenue and EBITDA were in-line with its estimates, while PAT was better than expected due to lower minority interest for the quarter.

It has however trimmed its earnings estimate for the stock to factor in procedural time required to add Insulin Aspart biosimilar in the formulary list, gradual reduction in interest costs, and R&amp;amp;D spending to boost product pipeline across the biosimilar/generics segments.

“Following an earnings revival in FY25, BIOS is entering a scale-up phase, poised for strong earnings growth driven by robust traction across segments and improved profitability. Ongoing financial deleverage is expected to further enhance earnings prospects,” it added.

Goldman Sachs on Biocon:

Goldman Sachs remained ‘Neutral’ on the stock, but raised its target price to Rs 375 per share. This implies a downside potential of nearly 8 percent from the stock’s previous closing price.

The international brokerage said that the results beat estimates driven largely by beats from the generics and biologics segments

HBSC Research on Biocon:

HBSC Research held a ‘Buy’ call on the stock, and raised its target price to Rs 455 per share. This implies an upside potential of more than 12 percent from the stock’s previous closing price.

The international brokerage said that it remains positive on imminent turnaround of company's biosimilars segment.

Also read: Our LIVE blog on stock market updates

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

<a href="https://www.moneycontrol.com/india/stockpricequote/electronics-components/marineelectricalsindia/ME21">Marine Electricals</a> share price rose 7 percent intraday on November 13 following the multiple orders win worth Rs  174.60 crore

The comapny has bagged an order from Siemens for supply of power distribution system to be supplied for a Global Hyperscaler for their JUI1A DC project.

The delivery of the said order is scheduled to be completed over a period of 12 months.

Also, received order from Hindustan Shipyard for carrying out electrical works on board vessel 11200, while is scheduled to be completed over a period of 36 months.

The company also received order from Equinix India for supply, installation, testing and commissioning of power distribution systems for MB3.2 DC project.

The delivery of said order is scheduled to be completed over a period of four months.

The share touched a 52-week high of Rs 333.00 and a 52-week low of Rs 138.90 on 17 December, 2024 and 04 March, 2025, respectively.

Currently, the stock is trading 25.8 percent below its 52-week high and 77.9 percent above its 52-week low.

The market capitalisation of the company stands at Rs 3,408.61 crore.

With the receipt of these orders, the current order book position of the company as on date is around Rs 966 crore.

Marine Electricals shares gain 7% on orders win of Rs 174.60 crore

Marine Electricals share price rose 7 percent intraday on November 13 following the multiple orders win worth Rs  174.60 crore

The comapny has bagged an order from Siemens for supply of power distribution system to be supplied for a Global Hyperscaler for their JUI1A DC project.

The delivery of the said order is scheduled to be completed over a period of 12 months.

Also, received order from Hindustan Shipyard for carrying out electrical works on board vessel 11200, while is scheduled to be completed over a period of 36 months.

The company also received order from Equinix India for supply, installation, testing and commissioning of power distribution systems for MB3.2 DC project.

The delivery of said order is scheduled to be completed over a period of four months.

The share touched a 52-week high of Rs 333.00 and a 52-week low of Rs 138.90 on 17 December, 2024 and 04 March, 2025, respectively.

Currently, the stock is trading 25.8 percent below its 52-week high and 77.9 percent above its 52-week low.

The market capitalisation of the company stands at Rs 3,408.61 crore.

With the receipt of these orders, the current order book position of the company as on date is around Rs 966 crore.

Printing & Publishing Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Printing & Publishing industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Stocks to Watch Today: Hero Moto, Tata Motors, Pine Labs, Sagility, Zydus Life, LG Electronics, NBCC, Nippon Life, BDL, Muthoot Finance, Vishal Mega Mart in focus on 14 November

National Investment and Infrastructure Fund sells 2.28% stake in Ather Energy to 8 investors

Yatra Online shares jump 35% in three days as brokerages raise target prices after strong Q2 results

Biocon shares surge 10% in two days as brokerages cheer firm’s strong Q2 results: Check latest target prices

Marine Electricals shares gain 7% on orders win of Rs 174.60 crore

Printing & Publishing Industry StocksCheck latest stock performance, list of stocks, earnings review & more details about the Printing & Publishing industry stocks.

Gainers/Losers

Industry Market Map

Earnings Review-Q2 FY25-26

Stock News

Stocks to Watch Today: Hero Moto, Tata Motors, Pine Labs, Sagility, Zydus Life, LG Electronics, NBCC, Nippon Life, BDL, Muthoot Finance, Vishal Mega Mart in focus on 14 November

National Investment and Infrastructure Fund sells 2.28% stake in Ather Energy to 8 investors

Yatra Online shares jump 35% in three days as brokerages raise target prices after strong Q2 results

Biocon shares surge 10% in two days as brokerages cheer firm’s strong Q2 results: Check latest target prices

Marine Electricals shares gain 7% on orders win of Rs 174.60 crore

Printing & Publishing Industry Stocks
Check latest stock performance, list of stocks, earnings review & more details about the Printing & Publishing industry stocks.